Santa Cruz Biotechnology delivers a wide array of PRDM12 monoclonal antibodies for advanced research in molecular biology. PRDM12 monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PRDM12 belongs to the PRDM family, which plays significant roles in gene regulation and cellular differentiation. PRDM12 functions in the development of sensory neurons and influences the regulation of pain pathways. Research has shown that PRDM12 expression patterns vary across different tissue types and developmental stages. Understanding PRDM12's molecular mechanisms can provide insights into neurodevelopmental processes. Investigating PRDM12's role in pain pathways may reveal potential therapeutic targets for pain management. Current studies continue to uncover new aspects of PRDM12's biological functions and regulatory mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of PRDM12's role in neurological development and pain regulation.